Seeing Is Believing

Currently out of the existing stock ratings of Matt Miksic, 348 are a BUY (75%), 88 are a HOLD (18.97%), 28 are a SELL (6.03%).
Analyst Matt Miksic, currently employed at BARCLAYS, carries an average stock price target met ratio of 47.9% that have a potential upside of 19.73% achieved within 268 days.
Matt Miksic’s has documented 934 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services sectors.
Most recent stock forecast was given on ISRG, Intuitive Surgical at 13-Jul-2026.
Analyst best performing recommendations are on HSIC (HENRY SCHEIN).
The best stock recommendation documented was for ISRG (INTUITIVE SURGICAL) at 10/17/2022. The price target of $235 was fulfilled within 8 days with a profit of $44.88 (23.61%) receiving and performance score of 29.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jan-2017
$135
$37.5 (38.46%)
$135
25 days ago
(08-Sep-2026)
23/35 (65.71%)
$29.48 (27.94%)
340
Hold Since 13-Aug-2026
$130
$32.5 (33.33%)
1 months 20 days ago
(13-Aug-2026)
2/3 (66.67%)
$18.73 (16.83%)
29
Buy Since 28-Jul-2026
$125
$27.5 (28.21%)
$117
2 months 5 days ago
(28-Jul-2026)
3/4 (75%)
$17.73 (16.53%)
150
Buy Since 06-Jun-2019
$112
$14.5 (14.87%)
$136
2 months 16 days ago
(17-Jul-2026)
21/29 (72.41%)
$11.32 (11.24%)
409
Buy Since 19-Sep-2024
$118
$20.5 (21.03%)
$115
2 months 16 days ago
(17-Jul-2026)
4/8 (50%)
$17.32 (17.20%)
120
Which stock is Matt Miksic most bullish on?
Which stock is Matt Miksic most reserved on?
What Year was the first public recommendation made by Matt Miksic?